Expanded Access Policy
At this time, our investigational drug neflamapimod is only available through participation in one of our ongoing clinical trials. Neflamapimod is not available on an expanded access basis, including for single patient compassionate use.
Scientific data for neflamapimod has been published in certain medical journals and presented to the medical and scientific community at various medical meetings. Click below to access the data presentations.
PRESENTATIONS AND PUBLICATIONS
Resources for Patients and Caregivers
MORE ABOUT THE DISEASE
Lewy Body Dementia Association (LBDA)
Alzheimer’s Association: Lewy Body Dementia
National Institute on Aging (NIH)
Cleveland Clinic
POLICIES
Expanded Access Policy
Financial Conflict of Interest Policy